We offer a variety of scales and services for mammalian cell culture, microbial fermentation, cell therapy, pDNA, mRNA, and viral vectors
CDMO manufacturing services
AGC Biologics has successfully manufactured more than 200 biological projects for pre-clinical studies through commercial approvals. Our teams of scientists at our cell and viral vector gene therapy sites have more than two decades of manufacturing experience.
Our seven state-of-the-art facilities across the globe offer innovative design, expanding capacity, technological ingenuity, and teams dedicated to strict biopharmaceutical regulations required for cGMP operations.
Industry analysis: The importance of pharmacuetical cGMP compliance
To stay ahead of industry trends and maintain rigorous regulatory requirements, it is vital to have a deep understanding of cGMP and how best to ensure compliance within a production environment.Download
Fill out the form to access "cGMP Compliance in a Growing Biologics Market"
AGC Biologics maintains cGMP practices for all protein-based biologics and advanced therapy manufacturing services
We have developed more than 60 mammalian cell lines and processes from pre-clinical through commercial production.
We have successfully expressed antibody fragments, growth factors, antigens, enzymes, and other proteins using multiple modes of expression.
We offer supplies in different qualities, and development scales and have extensive in-house analytical methods for today's latest applications.
Our non-GMP or GMP supply of material supports vaccine creation, RNA drugs, gene therapy and viral vector starting materials, and more.